Arvinas (ARVN) Debt Ratio (2017 - 2026)
Arvinas (ARVN) recorded quarterly Debt Ratio of 0.0 in Q1 2026, down 16.85% quarter-over-quarter from 0.0 in Q4 2025, and down 7.23% on a YoY basis from 0.0 in Q1 2025.
Arvinas (ARVN) Debt Ratio (2017 - 2026) Analysis & Trends
Arvinas' Debt Ratio history runs 10 years deep, the most recent figure standing at 0.0 for Q1 2026.
- In Q1 2026, Debt Ratio fell 7.23% year-over-year to 0.0; the TTM figure through Mar 2026 stood at 0.0 (down 7.23% YoY), while the FY2025 annual figure was 0.0, up 1.35% from the prior year.
- Debt Ratio was 0.0 for Q1 2026 at Arvinas, down from 0.0 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.0 in Q3 2023 to a low of 0.0 in Q1 2026.
- Historically, Debt Ratio has averaged 0.0 across 5 years, with a median of 0.0 in 2024.
- The sharpest annual moves came in 2022 and 2023: Debt Ratio sank 77.1% in 2022, then rose 29.86% in 2023.
- A 5-year view of Debt Ratio shows it stood at 0.0 in 2022, then decreased by 22.2% to 0.0 in 2023, then retreated by 10.35% to 0.0 in 2024, then rose by 1.35% to 0.0 in 2025, then dropped by 16.85% to 0.0 in 2026.
- The last three Debt Ratio figures came in at 0.0 (Q1 2026), 0.0 (Q4 2025), and 0.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.18 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Arvinas | 492.16 Mn | -122.74 Mn | - | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | 0.00 |